Lenacapavir (brand name: Sunlenca) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults for whom other HIV medicines have not worked and who meet certain requirements, as determined by a health care provider .
Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. It is taken by mouth or by subcutaneous injection. Medical uses · History · Society and culture |
Lenacapavir is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can ... |
Lenacapavir is a first-in-class capsid inhibitor being investigated for use in HIV-1 treatment. |
26 июл. 2024 г. · LEN is a HIV-1 capsid inhibitor that is delivered by subcutaneous injection twice a year for HIV prevention. The PURPOSE 1 study showed zero new ... |
6 мар. 2023 г. · Lenacapavir is a medication used to treat HIV, marketed under the brand name Sunlenca. It is taken in combination with other antiretroviral drugs. |
15 февр. 2023 г. · Lenacapavir injection is used along with other medications to treat human immunodeficiency virus type 1 (HIV-1) in certain adults. |
Lenacapavir is also being studied as an investigational drug to prevent HIV infection. Lenacapavir belongs to a group of HIV drugs called capsid inhibitors. |
31 янв. 2024 г. · Lenacapavir injection is used together with other medicines to treat human immunodeficiency virus (HIV) infection in patients who have previously received ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |